Article info
PDFOriginal article
Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury
- Correspondence to Jason E Smith, Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham B15 2TH, UK; jasonesmith{at}nhs.net
Citation
Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury
Publication history
- Received July 27, 2018
- Revision received July 28, 2018
- Accepted July 30, 2018
- First published November 12, 2018.
Online issue publication
January 24, 2019
Article Versions
- Previous version (24 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Crown copyright (2018), Dstl. This material is licensed under the terms of the Open Government Licence except where otherwise stated. To view this licence, visit http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gsi.gov.uk.